See also this year's filing and all EDGAR filings for this company.
PDF Report 0001560241_2024_G1_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001560241, G1 Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 114,948,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,476,000 |
| 3 | remainder_Assets | 5,116,000 |
| 4 | LiabilitiesCurrent | 29,716,000 |
| 5 | LiabilitiesNoncurrent | 4,381,000 |
| 6 | remainder_Liabilities | 52,057,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | -118,446 |
| 9 | ResearchAndDevelopmentExpense | 36,076,816 |
| 10 | remainder_Expenses | 34,612,173 |
| 11 | remainder_Revenues | 79,508,980 |
| 12 | remainder_NetIncome | -4,662,486 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 121,540,000 |
| 1 | Liabilities | 86,154,000 |
| 2 | Expenses | 70,570,543 |
| 3 | Revenues | 79,508,980 |
| 4 | StockholdersEquity | 35,386,000 |
| 5 | NetIncome | 4,275,951 |
| 6 | ComprehensiveNetIncome | 4,275,951 |
| 7 | BaseVar | 181,218,004 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.784 |
| 9 | EconomicCapitalRatio | 2.13 |